SOPHiA GENETICS (NASDAQ:SOPH – Get Free Report) and Information Analysis (OTCMKTS:IAIC – Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, profitability, valuation, risk, dividends and analyst recommendations.
Valuation & Earnings
This table compares SOPHiA GENETICS and Information Analysis”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| SOPHiA GENETICS | $77.27 million | 8.99 | -$79.00 million | ($1.15) | -7.20 |
| Information Analysis | $13.90 million | 0.00 | $410,000.00 | $0.04 | N/A |
Analyst Recommendations
This is a summary of current recommendations for SOPHiA GENETICS and Information Analysis, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| SOPHiA GENETICS | 1 | 1 | 3 | 0 | 2.40 |
| Information Analysis | 0 | 0 | 0 | 0 | 0.00 |
SOPHiA GENETICS presently has a consensus price target of $10.00, indicating a potential upside of 20.77%. Given SOPHiA GENETICS’s stronger consensus rating and higher probable upside, equities research analysts clearly believe SOPHiA GENETICS is more favorable than Information Analysis.
Risk and Volatility
SOPHiA GENETICS has a beta of 0.96, indicating that its share price is 4% less volatile than the S&P 500. Comparatively, Information Analysis has a beta of 3.25, indicating that its share price is 225% more volatile than the S&P 500.
Insider & Institutional Ownership
31.6% of SOPHiA GENETICS shares are owned by institutional investors. 4.9% of SOPHiA GENETICS shares are owned by company insiders. Comparatively, 23.8% of Information Analysis shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Profitability
This table compares SOPHiA GENETICS and Information Analysis’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| SOPHiA GENETICS | -93.86% | -132.47% | -45.97% |
| Information Analysis | 3.72% | 18.48% | 9.33% |
Summary
Information Analysis beats SOPHiA GENETICS on 8 of the 13 factors compared between the two stocks.
About SOPHiA GENETICS
SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Rolle, Switzerland.
About Information Analysis
Information Analysis, Inc. provides information technology services. The firm engages in the business of modernizing client information systems, developing and maintaining information technology systems, and performing consulting services to government and commercial organizations. It specializes in legacy systems modernization, ebusiness solutions, enterprise portals, system migration and re-hosting services, and enterprise application integration. The company was founded by Sandor Rosenberg in 1979 and is headquartered in Fairfax, VA.
Receive News & Ratings for SOPHiA GENETICS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SOPHiA GENETICS and related companies with MarketBeat.com's FREE daily email newsletter.
